COFCO Biotechnology Hits Day High with 7.62% Surge in Stock Price

COFCO Biotechnology Co., Ltd., a prominent player in the specialty chemicals industry, has shown significant activity today, gaining 7.62% on March 6, 2026. The stock reached an intraday high of CNY 7.40, reflecting a strong performance compared to the China Shanghai Composite, which only increased by 0.38% on the same day. Over the past week, COFCO Biotechnology has outperformed the broader market with an 8.42% rise, and its one-month performance stands at 13.45%. Year-to-date, the stock has delivered a robust return of 27.21%, significantly higher than the 3.91% increase in the China Shanghai Composite. Despite its recent gains, the company faces challenges with a high debt-to-equity ratio and a history of declining net sales and operating profit over the past five years. However, COFCO Biotechnology has reported positive results for the last four consecutive quarters, with a notable increase in net profit and operating cash flow. The stock's return on equity stands at 0.69%, and it maintains an attractive valuation with a price-to-book ratio of 1.13.